OBJECTIVE: To explore intravoxel incoherent motion (IVIM) characteristics of nasopharyngeal carcinoma (NPC) and relationships with different tumour stages. METHODS: We prospectively recruited 80 patients with newly diagnosed undifferentiated NPC. Diffusion-weighted MR imaging was performed and IVIM parameters (D, pure diffusion; f, perfusion fraction; D*, pseudodiffusion coefficient) were calculated. Patients were stratified into low and high tumour stage groups based on American Joint Committee on Cancer (AJCC) and TNM staging for determination of the predictive powers of IVIM parameters using t test, multiple logistic regression and ROC curve analyses. RESULTS: D, f and D* were all statistically significantly lower in high-stage groups in AJCC, T and N staging. D, f and D* were all independent predictors of AJCC staging, f and D* were independent predictors of T staging, and D was an independent predictor of N staging. D was most powerful for AJCC and N staging, whereas f was most powerful for T staging. Optimal cut-off values (area under the curve, sensitivity, specificity, positive likelihood ratio, negative likelihood ratio) were as follows: AJCC stage, D = 0.782 × 10(-3) mm(2)/s (0.915, 93.3 %, 76.2 %, 3.92, 0.09); T staging, f = 0.133 (0.905, 80.5 %, 92.5 %, 10.73, 0.21); N staging, D = 0.761 × 10(-3) mm(2)/s (0.848, 87.5 %, 66.7 %, 2.62, 0.19). Multivariate analysis showed no diagnostic improvement. CONCLUSION: Nasopharyngeal carcinoma has distinctive intravoxel incoherent motion characteristics parameters in different tumour staging, potentially helping pretreatment staging. KEY POINTS: • Magnetic resonance imaging is increasingly used to assess nasopharyngeal carcinoma (NPC). • NPC has distinctive diffusion/perfusion characteristics at different stages. • Non-invasive MR imaging may help pretreatment staging prediction. • Diffusion properties of NPC best correlate with AJCC and N staging. • Perfusion properties of NPC best correlate with T staging.
OBJECTIVE: To explore intravoxel incoherent motion (IVIM) characteristics of nasopharyngeal carcinoma (NPC) and relationships with different tumour stages. METHODS: We prospectively recruited 80 patients with newly diagnosed undifferentiated NPC. Diffusion-weighted MR imaging was performed and IVIM parameters (D, pure diffusion; f, perfusion fraction; D*, pseudodiffusion coefficient) were calculated. Patients were stratified into low and high tumour stage groups based on American Joint Committee on Cancer (AJCC) and TNM staging for determination of the predictive powers of IVIM parameters using t test, multiple logistic regression and ROC curve analyses. RESULTS: D, f and D* were all statistically significantly lower in high-stage groups in AJCC, T and N staging. D, f and D* were all independent predictors of AJCC staging, f and D* were independent predictors of T staging, and D was an independent predictor of N staging. D was most powerful for AJCC and N staging, whereas f was most powerful for T staging. Optimal cut-off values (area under the curve, sensitivity, specificity, positive likelihood ratio, negative likelihood ratio) were as follows: AJCC stage, D = 0.782 × 10(-3) mm(2)/s (0.915, 93.3 %, 76.2 %, 3.92, 0.09); T staging, f = 0.133 (0.905, 80.5 %, 92.5 %, 10.73, 0.21); N staging, D = 0.761 × 10(-3) mm(2)/s (0.848, 87.5 %, 66.7 %, 2.62, 0.19). Multivariate analysis showed no diagnostic improvement. CONCLUSION:Nasopharyngeal carcinoma has distinctive intravoxel incoherent motion characteristics parameters in different tumour staging, potentially helping pretreatment staging. KEY POINTS: • Magnetic resonance imaging is increasingly used to assess nasopharyngeal carcinoma (NPC). • NPC has distinctive diffusion/perfusion characteristics at different stages. • Non-invasive MR imaging may help pretreatment staging prediction. • Diffusion properties of NPC best correlate with AJCC and N staging. • Perfusion properties of NPC best correlate with T staging.
Authors: Yuxi Pang; Baris Turkbey; Marcelino Bernardo; Jochen Kruecker; Samuel Kadoury; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke Journal: Magn Reson Med Date: 2012-04-09 Impact factor: 4.668
Authors: Dechen W Tshering Vogel; Peter Zbaeren; Andreas Geretschlaeger; Peter Vermathen; Frederik De Keyzer; Harriet C Thoeny Journal: Eur Radiol Date: 2012-08-04 Impact factor: 5.315
Authors: Z Xiao; Z Tang; J Qiang; S Wang; W Qian; Y Zhong; R Wang; J Wang; L Wu; W Tang; Z Zhang Journal: AJNR Am J Neuroradiol Date: 2018-01-25 Impact factor: 3.825
Authors: B K H Law; A D King; K S Bhatia; A T Ahuja; M K M Kam; B B Ma; Q Y Ai; F K F Mo; J Yuan; D K W Yeung Journal: AJNR Am J Neuroradiol Date: 2016-05-05 Impact factor: 3.825
Authors: Vincent Lai; Victor Ho Fun Lee; Ka On Lam; Henry Chun Kin Sze; Queenie Chan; Pek Lan Khong Journal: Eur Radiol Date: 2014-12-23 Impact factor: 5.315